Showing results (481-490 of 1,185) with videos related to
Sort By:
Pageof 119
Nephron. Clinical Practice|November 1, 2014
Functional status and mortality in chronic kidney disease: results from a prospective observational studyJames P Ritchie, Helen Alderson, Darren Green, et al.Nephron. Clinical Practice|October 23, 2013
The effects of racial differences on body composition and total body water measured by multifrequency bioelectrical impedance analysis influence delivered Kt/V dialysis dosingSanjeev Kumar, Maryam Khosravi, Annick Massart, et al.Nephron. Clinical Practice|November 18, 2014
JTT-751 for treatment of patients with hyperphosphatemia on peritoneal dialysisKeitaro Yokoyama, Takashi Akiba, Masafumi Fukagawa, et al.Nephron. Clinical Practice|November 18, 2014
Rituximab in adult minimal change disease and focal segmental glomerulosclerosisAndreas Kronbichler, Annette BruchfeldNephron. Clinical Practice|November 22, 2014
Complement and glomerular diseasesReena J Popat, Michael G RobsonNephron. Clinical Practice|May 11, 2006
Outcome and treatment of bucillamine-induced nephropathyJunichi Hoshino, Yoshifumi Ubara, Shigeo Hara, et al.Nephron. Clinical Practice|May 11, 2006
Coronary artery calcification, systemic inflammation markers and mineral metabolism in a peritoneal dialysis populationAdriano Luiz Ammirati, Maria Aparecida Dalboni, Miguel Cendoroglo, et al.Nephron. Clinical Practice|April 26, 2006
Reliability of magnetic resonance imaging for measuring the volumetric indices in autosomal-dominant polycystic kidney disease: correlation with hypertension and renal functionYoung Rae Lee, Kyu-Beck LeeNephron. Clinical Practice|April 29, 2006
Brain natriuretic peptide and N-terminal proBNP in chronic haemodialysis patientsJaroslav Racek, Hana Králová, Ladislav Trefil, et al.Nephron. Clinical Practice|February 28, 2004
Mesangiocapillary glomerulonephritis type 2 associated with familial partial lipodystrophy (Dunnigan-Kobberling syndrome)Katharine R Owen, Mollie Donohoe, Sian Ellard, et al.Pageof 119